Ailesel ve sporadik Parkinson hastalığında dokuma fare geninin insan homoloğu.
The human homologue of the weaver mouse gene in familial and sporadic Parkinson's disease.
DOI: 10.1016/0306-4522(96)00091-7PMID: 8735215
The human homologue of the weaver mouse gene in familial and sporadic Parkinson's disease.
DOI: 10.1016/0306-4522(96)00091-7PMID: 8735215
Ventroposterior medial pallidotomy in patients with advanced Parkinson's disease.
DOI: 10.1097/00006123-199606000-00055PMID: 8727163
Intranasal apomorphine rescue therapy for parkinsonian "off" periods.
DOI: 10.1097/00002826-199619030-00001PMID: 8726538
Adjunctive cabergoline therapy of Parkinson's disease: comparison with placebo and assessment of dose responses and duration of effect.
DOI: 10.1097/00002826-199619030-00002PMID: 8726539
Lack of relation between genetic polymorphism of cytochrome P-450IID6 and sporadic idiopathic Parkinson's disease.
DOI: 10.1097/00002826-199619030-00003PMID: 8726540
Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced parkinsonian patients.
DOI: 10.1097/00002826-199619030-00004PMID: 8726541
Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
DOI: 10.1097/00002826-199619030-00005PMID: 8726542
Effects of antimuscarinic antiparkinsonian drugs on brightness discrimination performance in rats.
DOI: 10.1016/0091-3057(95)02144-2PMID: 8743605
Cellular immune reactions in brain transplantation: effects of graft pooling and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease.
DOI: 10.1002/(sici)1098-1136(199606)17:2<103::aid-glia3>3.0.co;2-3PMID: 8776578
Familial autosomal dominant dopa responsive Parkinson's disease in three living generations showing extreme anticipation and childhood onset.
DOI: 10.1136/jmg.33.6.504PMID: 8782052
Obstructive and restrictive pulmonary dysfunctions in Parkinson's disease.
DOI: 10.1016/0022-510x(96)00003-2PMID: 8791248
Pharmacokinetic optimisation in the treatment of Parkinson's disease.
DOI: 10.2165/00003088-199630060-00004PMID: 8792058
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.